ALNY vs INHD · P/E 76, rev $1.29B vs rev $2.8M
Alnylam Pharmaceuticals Inc (ALNY) versus Inno Holdings Inc. Common Stock (INHD) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Inno Holdings Inc. Common Stock (INHD) is a steel company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported INHD revenue for 2025-09-30 was $2.8M. Net income was -$7.1M. Revenue was up 221.4% from 2024-09-30 to 2025-09-30. INHD currently screens at market cap $4.7M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. INHD currently screens at market cap $4.7M.
Not investment advice. Open the ALNY and INHD stock pages for the full models.
Not investment advice.